TMO Revenue 2026
Annual and quarterly sales data for Thermo Fisher Scientific Inc
Latest Annual Revenue
$42.88B
2024-12-31
YoY Growth
+0.1%
vs. previous year
4-Year CAGR
7.4%
compound growth
Annual Revenue History
2024-12-31
$42.88B
YoY Growth
+0.1%
2023-12-31
$42.86B
YoY Growth
-4.6%
2022-12-31
$44.91B
YoY Growth
+14.5%
2021-12-31
$39.21B
YoY Growth
+21.7%
2020-12-31
$32.22B
Quarterly Revenue Breakdown
2025-09-27
$11.12B
2025-06-28
$10.86B
2025-03-29
$10.36B
2024-09-28
$10.60B
2024-06-29
$10.54B
2024-03-30
$10.35B
2023-09-30
$10.57B
2023-07-01
$10.69B
Revenue by Segment
Get Full TMO Financial Analysis
View complete income statements, balance sheets, and AI-powered insights
Frequently Asked Questions
What is TMO's revenue?
TMO (Thermo Fisher Scientific Inc) reported $42.88 billion in revenue for 2024-12-31. This represents a 0.1% increase compared to the previous year.
How much revenue does TMO make per year?
Thermo Fisher Scientific Inc generates approximately $42.88 billion in annual revenue based on the most recent fiscal year ending 2024-12-31.
Is TMO revenue growing?
Yes, TMO's revenue is growing. The company achieved 0.1% revenue growth year-over-year. Over the past 4 years, revenue has grown at a compound annual growth rate (CAGR) of 7.4%.
What is TMO's quarterly revenue?
TMO reported $11.12 billion in revenue for the most recent quarter (2025-09-27). This is 2.5% higher than the previous quarter.
What are TMO's revenue sources?
TMO's revenue comes from multiple segments: Total Revenue. See the revenue breakdown below for detailed segment analysis.
How does TMO compare to competitors in revenue?
TMO generates $42.88 billion in annual revenue in the Health Care sector. Compare TMO to competitors using our stock comparison tool to see relative market share and growth rates.
Disclaimer: Revenue data is based on publicly filed financial statements. Historical performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.